Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
83.90
-3.39 (-3.88%)
Streaming Delayed Price
Updated: 12:00 PM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025
January 08, 2025
Via
The Motley Fool
Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 07, 2025
From
DexCom, Inc.
Via
Business Wire
These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024
January 04, 2025
Via
The Motley Fool
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
December 25, 2024
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.
Via
Chartmill
DEXCOM INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of DexCom, Inc. - DXCM
December 21, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
December 21, 2024
Via
The Motley Fool
Peering Into DexCom's Recent Short Interest
December 16, 2024
Via
Benzinga
Key Takeaways From DexCom Analyst Ratings
December 09, 2024
Via
Benzinga
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
December 17, 2024
From
DexCom, Inc.
Via
Business Wire
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
December 02, 2024
Via
The Motley Fool
Exploring the Growth Potential of NASDAQ:DXCM as It Nears a Breakout.
December 02, 2024
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout.
Via
Chartmill
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
November 11, 2024
Is DEXCOM INC (NASDAQ:DXCM) on the Verge of a Major Breakout as a Strong Growth Stock?
Via
Chartmill
Analyst Expectations For DexCom's Future
October 25, 2024
Via
Benzinga
These Analysts Revise Their Forecasts On DexCom Following Q3 Results
October 25, 2024
Via
Benzinga
2 Excellent Healthcare Stocks to Hold Through the Next Decade
November 28, 2024
Via
The Motley Fool
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
November 26, 2024
Via
The Motley Fool
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
November 24, 2024
Via
The Motley Fool
Dexcom and ŌURA Announce Strategic Partnership
November 19, 2024
From
DexCom, Inc.
Via
Business Wire
Large-Cap Stocks In Trouble - Sunday, Nov. 17
November 17, 2024
Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.
Via
Talk Markets
Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom
November 14, 2024
Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest Form 13F on Thursday and disclosed its trading activity from the prior quarter.
Via
Benzinga
Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
November 14, 2024
From
DexCom, Inc.
Via
Business Wire
Insulet Soars Out Of Buy Zone As 'Beat-And-Raise Cadence' Continues
November 08, 2024
Shares soared out of a buy zone after beating third-quarter forecasts and raising its outlook for 2024.
Via
Investor's Business Daily
1 Stock to Buy Near Its 52-Week Low and Hold for 10 Years
November 08, 2024
This medical device company is down but not out.
Via
The Motley Fool
Why DexCom Stock Flopped on Friday
October 25, 2024
Investors likely felt that with a compelling new product on the market, the company should have posted more meaningful growth.
Via
The Motley Fool
Nasdaq Up Triple Digits As Stocks Rally, Yields Cool
October 25, 2024
Stocks are finishing the week strong, but it's a pyrrhic victory, with two of the three major indexes still staring down sizable weekly losses.
Via
Talk Markets
Stock Market Mixed But Nasdaq Hits Record High As Tesla Leads Earnings Winners: Weekly Review
October 25, 2024
The major indexes were mixed for the week.
Via
Investor's Business Daily
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
October 25, 2024
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks.
Via
Benzinga
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
October 25, 2024
Via
Benzinga
DexCom (DXCM) Q3 2024 Earnings Call Transcript
October 24, 2024
DXCM earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.